New drug tested for patients whose immune systems attack their own blood
Disease control
Recruiting now
This early-stage trial is testing a new injectable drug called OM336 in adults whose immune systems mistakenly destroy their own red blood cells or platelets. The main goal is to check if the drug is safe and well-tolerated in people who have not fully responded to at least one p…
Phase: PHASE1 • Sponsor: Ouro Medicines • Aim: Disease control
Last updated Mar 23, 2026 15:29 UTC